Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension

por Verweij, Pierre, Danaietash, Parisa, Flamion, Bruno, Ménard, Joël, Bellet, Marc
Publicado 2020

Identifying and treating resistant hypertension in PRECISION: A randomized long‐term clinical trial with aprocitentan

por Danaietash, Parisa, Verweij, Pierre, Wang, Ji‐Guang, Dresser, George, Kantola, Ilkka, Lawrence, Mary Katherine, Narkiewicz, Krzysztof, Schlaich, Markus, Bellet, Marc
Publicado 2022

Efficacy and safety of setipiprant in seasonal allergic rhinitis: results from Phase 2 and Phase 3 randomized, double-blind, placebo- and active-referenced studies

por Ratner, Paul, Andrews, Charles P., Hampel, Frank C., Martin, Bruce, Mohar, Dale E., Bourrelly, Denis, Danaietash, Parisa, Mangialaio, Sara, Dingemanse, Jasper, Hmissi, Abdel, van Bavel, Jay
Publicado 2017